Predictors of underutilization of lung cancer screening: a machine learning approach.

Eur J Cancer Prev

Department of Software and Information Systems, College of Computing and Informatics, University of North Carolina.

Published: November 2022

Lung cancer is the second common cancer and a leading cause of cancer-related death in the US. Unfavorably, the prevalence of using low-dose computed tomography (LDCT) for lung cancer prevention in the US has remained below 4% over time. The purpose of this study is to develop machine learning models to analyze interactive pathways of factors associated with lung cancer screening use with the LDCT. The study was based on the data retrieved from the 2018 Behavioral Risk Factor Surveillance System. After dealing with missing values, 86 variables and 710 samples were included in the decision tree model and the random forest model. The data were randomly split into training (569/710, 80%) and testing (141/710, 20%) sets. Gini impurity is used to select and determine the optimal split of the nodes in the model. Machine learning performance was evaluated by model accuracy, sensitivity, specificity, F1 score, etc. The average performance metrics of the decision tree model were obtained: average accuracy is 67.78%, F1 score is 65.76%, sensitivity is 62.52%, and specificity is 73.57% based on 100 runs. In the decision model, nine interactive pathways were identified among the following factors: average drinks per month, BMI, diabetes, first smoke age, years of smoking, year(s) quit smoking, sex, last sigmoidoscopy or colonoscopy, last dental visit, general health, insurance, education, and last Pap test. Lung cancer screening utilization is the result of the interplay of multifactors. Lung cancer screening programs in clinical settings should not only focus on patients' smoking behaviors but also consider other socioeconomic factors.

Download full-text PDF

Source
http://dx.doi.org/10.1097/CEJ.0000000000000742DOI Listing

Publication Analysis

Top Keywords

lung cancer
24
cancer screening
16
machine learning
12
interactive pathways
8
decision tree
8
tree model
8
cancer
7
lung
6
model
6
predictors underutilization
4

Similar Publications

We report a case of Acanthamoeba infection in an HCT recipient with steroid-refractory GVHD. We highlight the multiple challenges that free-living ameba infections present to the clinician, the clinical laboratory, transplant infectious disease for review, hospital epidemiology if nosocomial transmission is considered, and public health officials, as exposure source identification can be a significant challenge. Transplant physicians should include Acanthamoeba infections in their differential diagnosis of a patient with skin, sinus, lung, and/or brain involvement.

View Article and Find Full Text PDF

Polymer based nanoformulations offer substantial prospects for efficacious chemotherapy delivery. Here, we developed a pH-responsive polymeric nanoparticle based on acidosis-triggered breakdown of boronic ester linkers. A biocompatible hyaluronic acid (HA) matrix served as a substrate for carrying a doxorubicin (DOX) prodrug which also possesses natural affinity for CD44 cells.

View Article and Find Full Text PDF

Histologic transformation from non-small cell to small cell lung cancer (SCLC) is a resistance mechanism to immune checkpoint inhibitors. We report herein a case of lung adenocarcinoma who developed liver and brain metastases during adjuvant atezolizumab therapy. The patient underwent a craniotomy to resect a brain metastasis, which was pathologically diagnosed as SCLC.

View Article and Find Full Text PDF

Background: Lung cancer surgery is associated with a high incidence of chronic postsurgical pain (CPSP), which necessitates long-term analgesic prescriptions. However, while essential for managing pain, these have shown various adverse effects. Current guidelines recommend using peripheral nerve blocks over epidural anaesthesia for perioperative analgesia in minimally invasive thoracic surgery (MITS).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!